SCHEMBL1840765

SCHEMBL1840765

COc1nc2c(N)nc(N)nc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DHFR P00374 4/20 0.38
PIK3CG P48736 1/20 0.35
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10121590 0.83 ADORA3 (0.32)
SCHEMBL13811523 0.81
SCHEMBL2953678 0.78 ADORA3 (0.38) DHFR
SCHEMBL10121645 0.76 ADORA2A (0.31)
SCHEMBL1146282 0.76 PDE4B (0.34)
SCHEMBL12857099 0.76 CYP1A2 (0.38)
SCHEMBL887193 0.76 MAP4K4 (0.39) PIK3CG
SCHEMBL2542341 0.74 TLR7 (0.41)
SCHEMBL14224934 0.73 ADORA2A (0.40)
SCHEMBL13849616 0.73 KCNH3 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324026-A1 PURINE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC, INFLAMMATORY AND INFECTIOUS DISEASES Smithkline Beecham Corporation (US) 2011-05-25 EP disclosed
EP-2320905-A1 NOVEL ADENINE DERIVATIVES Smithkline Beecham Corporation (US) 2011-05-18 EP disclosed